Iron sucrose
 | |
| Clinical data | |
|---|---|
| Trade names | Venofer |
| AHFS/Drugs.com | FDA Professional Drug Information |
| Routes of administration | Intravenous |
| ATC code | |
| Legal status | |
| Legal status |
|
| Chemical and physical data | |
| Formula | [Na2Fe5O8(OH) •3(H2O)]n •m(C12H22O11) |
| Molar mass | 34,000 to 60,000 g/mol |
Iron sucrose (brand name Venofer) is an intravenously administered iron product indicated in the treatment of iron deficiency anemia.[1] It is frequently used in patients undergoing hemodialysis, those undergoing erythropoietin therapy, and/or patients who have chronic kidney disease. It is a type 2 complex which limits the maximum dose that can be given to 1000mg which requires 5-10 administrations. Unlike previous generations of IV iron supplements, this drug does not contain dextran.
The drug consists of ferric hydroxide solubilized in aqueous sucrose. Upon IV administration, the iron is distributed to ferritin, the normal iron storage protein.[2]
References
- ^ "Iron Sucrose (Intravenous Route)". Mayo Clinic. Retrieved 22 January 2016.
- ^ "In-Depth Review: Iron sucrose: The oldest iron therapy becomes new". American Journal of Kidney Diseases. 40: 1111–1121. 2002. doi:10.1053/ajkd.2002.36853.
{{cite journal}}: Cite uses deprecated parameter|authors=(help)
External links
- Venofer venofer on Drugs.com
- Venofer brand website
 | This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |